Professor Truswell's recent discussion (Truswell, 2005) of our two systematic reviews published in the Cochrane Library (Hooper et al., 2000 (Hooper et al., , 2004 focused on the much shorter summary publications published in the British Medical Journal. This is a pity as many of the points he raises were dealt with in the full-length Cochrane reviews. While giving voice to those who criticized our BMJ reviews, he failed to take note of our rebuttals (Hooper et al., 2001 (Hooper et al., , 2003 . Here we will deal with the major criticisms he makes of our work.
We agree with Truswell that observational data should be used as part of the nutrition evidence base. This is clearly the case for questions relating to causality where evidence derived from long-term cohort studies is often the only evidence that is available, and possibly ever will be available -for example, effects of obesity on disease outcomes. He considers that ''randomisation is not important for dietary experiments in which all participants are exposed to the same experimental diety'' but many questions in nutrition are concerned with long-term effects and with comparisons of alternative options where this design would be useless.
Systematic review methodology
Truswell questions our methodology and the studies we included in our systematic reviews. It is standard practice in any scientific study to have a protocol specifying hypotheses and methods (e.g., inclusion and exclusion criteria, outcomes, etc.). Cochrane reviews have such protocols that are peer-reviewed, other reviews do not necessarily adhere to this degree of rigour. The Finnish study (Turpeinen et al., 1968; Miettinen et al., 1972) was excluded from the dietary fat review because we had stated in the protocol that studies would only be included where they were randomized and, if cluster randomized, at least six clusters were involved -in the Finnish study, with no indication that the order of intervention was randomized and only two hospitals (clusters), the risk of bias is high and the study clearly not eligible.
The trials Truswell considers 'inadequate' were those that were found in a comprehensive search and found to provide relevant evidence for our question. Trials with few participants were included in both reviews as, in meta-analysis, pooling data increases power to detect clinically important differences in effects. Moreover, it is not the sample size that matters for study power, but the number of events. He states that the studies we included were not long enough, but all were at least 6 months long (excluding hundreds of otherwise eligible studies). We deliberately included studies of people with low, moderate and high risk of cardiovascular disease (CVD) to allow assessment of the effect of such risk status on the effect of dietary advice.
Coronary heart disease and stroke events: combining or not?
It is informative to compare the estimates derived from our combined CVD outcome and Truswell's own selective review of the evidence. They are actually consistent with each other if the 95% confidence intervals are examined. The inclusion of the large Finnish mental hospital study has the perhaps gratifying effect of producing a significant P-value. He ignores two decades of growing realization that confidence intervals rather than arbitrary levels of statistical significance are of greater importance in making inferences (Sterne and Davey Smith, 2001 ). There is evidence that cholesterol is linked positively with ischaemic (but not haemorrhagic) stroke, but Truswell chooses not to cite this (Iso et al., 1989; Wannamethee et al., 2000) .
Observational and randomized evidence: bias and confounding
The problems with cohort or non-randomized trial data are of bias and confounding. A recent methodological review concluded that 'Non-randomised studies may still give seriously misleading results when treated and control groups appear similar in key prognostic factors. Standard methods of case-mix adjustment do not guarantee removal of bias. Residual confounding may be high even when good prognostic data are available, and in some situations adjusted results may appear more biased than unadjusted results (Deeks et al., 2003) '. Even when the research question is concerned with causation rather than the effects of health care or health promotion, observational evidence is problematic. We would be interested in Truswell's views on the discordance between observational data showing vitamin C, vitamin E and folate intake (and their supplementation) are cardio-protective and randomized evidence showing that they do not influence risk (Heart Protection Study Collaborative Group, 2002; Davey Smith and Ebrahim, 2005) . It is clear that a problem often underestimated in nutritional research is the profound potential effect of confounding -that is, apparent causal links between nutritional intake and disease that are explained by a third, confounding, factor that is associated with both exposure and outcome. Confounding arises because of clustering of dietary behaviours with other 'healthy' lifestyle attributes -those who eat less saturated fat or salt are more likely to be wealthier, better educated, have better social support, be non-smokers, take sufficient physical activity and eat plenty of fruit, vegetables, nuts, whole grains, low-fat dairy food, etc. Adjusting for a handful of these components does not guarantee complete control of such confounding. For example, in the EPIC study, plasma vitamin C levels were strongly associated with coronary heart disease, which is biologically plausible given its antioxidant properties (Khaw et al., 2001) , but this increased risk associated with vitamin C levels in one observational study has been shown to be essentially abolished if a much wider range of potential behavioural, physiological and socio-economic confounding factors are taken into account (Lawlor et al., 2005) . This is not an isolated case, and the hazards of making policy and practice recommendations on the basis of observational evidence are currently under scrutiny (Davey Potter, 2005) . Within the area of diet and CVD, there are several clear cases of meta-analyses of cohort studies producing quite different results than pooling of RCTs, for example the effects of b-carotene on cardiovascular mortality (where cohorts showed significant protection by b-carotene and the pooled RCTs showed significant harm) (Egger et al., 1998; Vivekananthan et al., 2003) and vitamin E on cardiovascular mortality (where again cohorts showed significant protection whereas RCTs showed no effect or harm) (Shekelle et al., 2004; Miller et al., 2005) .
What is the question?
Our salt review did not set out to assess whether reduction in salt intake reduced cardiovascular diseases, but rather whether dietary advice to encourage people to make such changes has the effect of improving health. This is a relevant question for health services policy and will provide some indication of whether GPs and practice nurses should spend their time advising adults to reduce salt intake.
Conversely, we did want to assess whether reducing saturated fat intake by any means reduces CVDs. We included studies where people who were living in institutions were provided with a carefully controlled food intake as well as studies that advised reduction of saturated fat to people living in the community (with varying success). We used subgrouping to explore whether the effects were different in the two groups -there were no clear differences. More interesting was length of follow upstudies that continued for over 2 years showed a clear and important reduction in cardiovascular events regardless of how the reduction in saturated fat was delivered (rate ratio of 0.76, 95% CI 0.65-0.90), although studies with a 6 months to 2 years follow-up period did not show beneficial effects. This is interesting as it has relevance to our long-term support of people undertaking healthier diets and suggests that the major impact of reducing saturated fat may be on atherosclerosis rather than thrombosis.
Citation of systematic reviews as evidence
Truswell believes that our review was not valued because it was not cited in a WHO/FAO expert consultation. However, this consultation took place in January 2002, with papers prepared before our BMJ paper was available. It is also worth noting the tendency for greater citation of reviews demonstrating large effect sizes, a point we have previously made in the context of salt restriction and blood pressure, where the Law and Wald review, showing an improbably large effect (and containing non-randomized data), is substantially more widely cited than systematic reviews showing more consistent and plausible effect sizes (Hooper et al., 2003) . Expert group consultations are vulnerable to this type of bias unless explicitly systematic methods are used to assess both primary and secondary sources of evidence.
Conclusions made by expert committees
We are in complete agreement with any expert committee that concludes that reducing saturated fats and salt intake will be beneficial for health. The UK Advisory Committee on Nutrition (Scientific Advisory Committee on Nutrition, 2003) , which cited our dietary advice for salt review, accepted our findings that dietary advice is not particularly effective and consequently the focus is now on food labelling and reduction of hidden salt in processed food. Quite independently of our findings, Graudal (Graudal, 2005) commented recently that the work on dietary salt restriction and health had produced remarkably little evidence of effect -a 1 mm Hg reduction in systolic blood pressure -and questioned whether it had been worth all the effort.
What should the Cochrane Collaboration do?
Truswell supposes that BMJ correspondents who did not like our review would expect the Cochrane Collaboration to take some sort of action to avoid these 'problems'. As two of us are directly involved in the Cochrane Heart Group, as editor and coordinating editor, we are probably in as good a position as anyone in the Collaboration to understand what should be done. Unlike print published reviews of the sort that Truswell prefers, Cochrane reviews can be updated, which permits new data to be included, allows criticisms to be acknowledged, discussed, and, where necessary, the review modified and improved.
The Cochrane Collaboration is inclusive and we would be delighted if Truswell and his team (or any other interested readers) would offer to produce protocols for the following systematic reviews that the Cochrane Heart Group would very much like to publish: a. What are the effects of food labelling interventions on dietary behaviours and cardiovascular risk factors in children and adults? b. What are the effects of reduction of salt and fat in processed food\ on cardiovascular risk factors in children and adults?
We believe that these are the appropriate questions to ask to provide the evidence that such policies will (or will not) deliver the hoped for results. If Truswell thinks he already knows the answers to these questions, it is worth taking note of a major trial of smoking cessation, which used both state of the art community and individual interventions in tandem, but failed to demonstrate any effect on smoking behaviour (COMMIT trial collaborators, 1995) . Unfortunately, the evidence does not always work out as we would like it to -finding interventions that really work requires good primary studies and systematic reviews to locate all the relevant evidence. 
